Avid Bioservices, Inc.
Index- P/E14.13 EPS (ttm)1.29 Insider Own0.30% Shs Outstand62.39M Perf Week3.76%
Market Cap1.14B Forward P/E195.59 EPS next Y0.09 Insider Trans-24.11% Shs Float61.26M Perf Month10.51%
Income116.50M PEG0.94 EPS next Q0.00 Inst Own- Short Float / Ratio9.47% / 9.65 Perf Quarter34.64%
Sales140.70M P/S8.11 EPS this Y-95.20% Inst Trans5.45% Short Interest5.80M Perf Half Y-5.60%
Book/sh2.97 P/B6.12 EPS next Y615.38% ROA26.30% Target Price21.75 Perf Year-17.88%
Cash/sh0.95 P/C19.06 EPS next 5Y15.00% ROE64.70% 52W Range11.30 - 22.20 Perf YTD32.10%
Dividend- P/FCF- EPS past 5Y86.70% ROI41.20% 52W High-18.06% Beta1.80
Dividend %- Quick Ratio1.00 Sales past 5Y15.70% Gross Margin21.40% 52W Low60.97% ATR0.93
Employees321 Current Ratio1.50 Sales Q/Q20.60% Oper. Margin2.70% RSI (14)57.59 Volatility3.92% 6.30%
OptionableYes Debt/Eq0.77 EPS Q/Q-79.50% Profit Margin82.80% Rel Volume0.79 Prev Close18.58
ShortableYes LT Debt/Eq0.77 EarningsMar 13 AMC Payout0.00% Avg Volume601.43K Price18.19
Recom1.70 SMA207.22% SMA509.41% SMA20010.31% Volume472,751 Change-2.10%
Mar-14-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $20
Dec-08-21Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-17-21Initiated RBC Capital Mkts Outperform $21
Nov-10-20Initiated KeyBanc Capital Markets Overweight $12
Dec-10-19Upgrade First Analysis Sec Outperform → Strong Buy
Oct-17-19Initiated Stephens Overweight $8
Oct-16-19Initiated Craig Hallum Buy $11
Jun-28-19Upgrade Janney Neutral → Buy $10
May-09-19Downgrade Janney Buy → Neutral
Mar-14-23 12:35PM
Mar-13-23 05:55PM
04:05PM Loading…
Mar-10-23 07:24AM
Mar-06-23 04:05PM
Feb-23-23 10:50AM
Feb-16-23 08:43AM
Feb-14-23 04:33PM
Dec-09-22 01:39PM
Dec-06-22 05:35PM
04:05PM Loading…
Nov-29-22 04:05PM
Nov-17-22 06:03AM
Nov-16-22 08:05AM
Nov-02-22 04:05PM
Oct-17-22 09:55AM
Oct-10-22 08:30AM
Oct-05-22 06:47AM
Sep-27-22 04:05PM
Sep-22-22 08:05AM
Sep-08-22 06:31AM
Sep-07-22 04:05PM
Sep-06-22 11:00PM
04:05PM Loading…
Sep-01-22 08:05AM
Aug-30-22 04:05PM
Aug-18-22 12:42PM
Aug-02-22 09:11PM
Jun-30-22 07:31AM
Jun-29-22 04:05PM
Jun-22-22 04:05PM
Jun-16-22 08:00AM
Jun-14-22 08:05AM
Jun-13-22 08:05AM
May-16-22 12:43PM
May-11-22 08:13AM
Apr-05-22 01:21PM
Mar-16-22 04:05PM
Mar-08-22 11:00PM
Mar-01-22 04:05PM
Feb-27-22 10:56PM
Feb-25-22 06:15PM
Feb-23-22 06:45PM
Feb-21-22 11:26AM
Feb-16-22 06:15PM
Feb-10-22 06:15PM
Feb-04-22 05:11AM
Feb-03-22 09:38AM
Feb-01-22 06:15PM
Jan-21-22 06:15PM
Jan-14-22 11:22AM
Jan-10-22 08:05AM
Jan-07-22 01:38PM
Dec-30-21 04:51AM
Dec-29-21 02:16PM
Dec-21-21 06:41AM
Dec-15-21 10:00AM
Dec-09-21 11:55AM
Dec-08-21 03:14AM
Dec-07-21 11:30PM
Dec-06-21 11:32AM
Dec-03-21 11:58AM
Dec-02-21 07:26PM
Nov-30-21 04:05PM
Nov-24-21 03:00PM
Nov-04-21 08:05AM
Oct-26-21 06:39PM
Oct-25-21 06:58PM
Oct-14-21 08:05AM
Oct-07-21 08:05AM
Oct-01-21 09:33AM
Sep-14-21 10:00AM
Sep-09-21 03:00PM
Sep-08-21 04:05PM
Sep-02-21 04:05PM
Sep-01-21 04:05PM
Aug-08-21 03:59AM
Jul-29-21 12:19PM
Jul-20-21 09:27AM
Jul-01-21 08:05AM
Jun-29-21 07:00PM
Jun-24-21 02:05AM
Jun-22-21 04:05PM
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hart Daniel RChief Financial OfficerMar 14Option Exercise5.662,00011,32048,957Mar 16 07:59 PM
Hart Daniel RChief Financial OfficerMar 14Sale19.005,00095,00046,957Mar 16 07:59 PM
Hancock Richard BDirectorMar 01Option Exercise4.675,00023,35044,134Mar 03 07:43 PM
Hancock Richard BDirectorMar 01Sale16.595,00082,97139,134Mar 03 07:43 PM
Hancock Richard BDirectorFeb 01Option Exercise4.675,00023,35044,134Feb 03 07:39 PM
Hancock Richard BDirectorFeb 01Sale16.025,00080,07739,134Feb 03 07:39 PM
Alegria Esther M.DirectorJan 13Sale16.325,32186,8560Jan 17 07:41 PM
Hancock Richard BDirectorJan 12Option Exercise4.582,62112,01140,769Jan 13 08:03 PM
Hancock Richard BDirectorJan 12Sale16.005,00080,00039,134Jan 13 08:03 PM
Green Nicholas StewartPresident & CEOJan 10Sale14.448,100116,97783,729Jan 11 07:38 PM
Hart Daniel RChief Financial OfficerJan 10Sale14.441,49921,64749,957Jan 11 07:45 PM
Ziebell Mark RV. P., General CounselJan 10Sale14.441,15016,60738,897Jan 11 07:46 PM
Hancock Richard BDirectorDec 02Option Exercise4.5310,00045,30046,881Dec 06 07:40 PM
Hancock Richard BDirectorDec 02Sale16.1110,000161,12236,881Dec 06 07:40 PM
Green Nicholas StewartPresident & CEOOct 10Sale17.907,493134,12176,615Oct 11 08:27 PM
Hart Daniel RChief Financial OfficerOct 10Sale17.901,26222,59047,020Oct 11 08:27 PM
Hancock Richard BDirectorOct 03Option Exercise4.575,00022,84140,516Oct 05 07:56 PM
Hancock Richard BDirectorOct 03Sale18.435,00092,13436,881Oct 05 07:56 PM
Hancock Richard BDirectorSep 01Option Exercise4.532,98713,53140,202Sep 02 07:50 PM
Hancock Richard BDirectorSep 01Sale17.123,32156,84436,881Sep 02 07:50 PM
Green Nicholas StewartPresident & CEOAug 01Sale19.2219,058366,27869,708Aug 02 08:14 PM
Hancock Richard BDirectorAug 01Sale19.405,00096,97937,215Aug 02 08:15 PM
Hart Daniel RChief Financial OfficerJul 11Sale17.754,32476,76844,661Jul 12 08:34 PM
Green Nicholas StewartPresident & CEOJul 11Sale17.752,93952,17651,266Jul 12 08:33 PM
Green Nicholas StewartPresident & CEOJul 08Sale17.5322,725398,41248,632Jul 11 07:41 PM
Hart Daniel RChief Financial OfficerJul 08Sale17.534,15072,75836,743Jul 11 07:42 PM
Hancock Richard BDirectorJul 05Option Exercise4.535,00022,65040,201Jul 06 08:01 PM
Hancock Richard BDirectorJul 05Sale16.035,00080,15735,201Jul 06 08:01 PM
Hancock Richard BDirectorJun 27Option Exercise4.673,80217,75542,738Jun 28 07:38 PM
Hancock Richard BDirectorJun 27Sale16.077,537121,08635,201Jun 28 07:38 PM
Hancock Richard BDirectorJun 24Option Exercise4.671,2115,65441,386Jun 28 07:38 PM
Hancock Richard BDirectorJun 24Sale16.022,46339,45438,936Jun 28 07:38 PM
Ziebell Mark RV. P., General CounselJun 17Option Exercise3.296,42821,14814,531Jun 21 07:33 PM
Green Nicholas StewartPresident & CEOApr 11Sale18.562,93954,55428,103Apr 12 07:50 PM
Hart Daniel RChief Financial OfficerApr 11Sale18.5672613,47628,770Apr 12 07:54 PM
Ziebell Mark RV. P., General CounselApr 11Sale18.563686,8318,103Apr 12 07:58 PM
Hancock Richard BDirectorApr 01Option Exercise4.675,00023,35040,200Apr 05 07:43 PM
Hancock Richard BDirectorApr 01Sale21.215,000106,06435,200Apr 05 07:43 PM